Avid Bioservices Inc (NASDAQ:CDMO)
| 18.09 BATS BZX Real-Time Price As of 2:13pm ET |  +0.62 / +3.55%Today’s Change | 11.30 Today|||52-Week Range 22.38 | +31.37% Year-to-Date |
Latest CDMO News | Press Releases
| Why Avid Bioservices Stock Is Surging Today Mar 14 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 17.47 |
| Today’s open | 17.64 |
| Day’s range | 17.41 - 18.09 |
| Volume | 4,126 |
| Average volume (3 months) | 614,145 |
| Market cap | $1.1B |
Data as of 2:13pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | +3,542.98% |
| Earnings growth (this year) | -84.54% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +24.75% |
| P/E ratio | 10.9 |
| Price/Sales | 7.93 |
| Price/Book | 6.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DCPHDeciphera Pharmaceut... | +0.28 | +1.90% |
| REPLReplimune Group Inc | -0.42 | -2.12% |
| PTGXProtagonist Therapeu... | +0.74 | +3.57% |
| SAVACassava Sciences Inc | -0.07 | -0.29% |
Data as of 2:18pm ET, 03/27/2023
Financials
| Next reporting date | June 28, 2023 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $119.6M |
| Annual profit (last year) | $127.7M |
| Net profit margin | 106.75% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tustin, California |
Forecasts
